Protalix Bio submits Type A meeting request to FDA for PRX-102 in Fabry disease
02 August 2021 - 9:07PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Protalix BioTherapeutics (AMEX:PLX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Protalix BioTherapeutics (AMEX:PLX)
Historical Stock Chart
From Apr 2023 to Apr 2024